News
Pharmaceuticals announced that the U.S. Food and Drug Administration has accepted for Priority Review the supplemental Biologics License Application for EYLEA HD Injection 8 mg. The sBLA seeks ...
Regulatory action was based on data from the Phase III QUASAR trial, which demonstrated that Eylea HD dosed every eight weeks ...
Regeneron Pharmaceuticals has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its Eylea HD eye drug.
Japanese drugmaker Chugai Pharmaceutical (TYO: 4519) announced that results from the Phase III clinical trial (NIHONBASHI ...
AstraZeneca has bought a priority review voucher (PRV) from Swedish biotech Sobi for $95 million, but isn’t revealing just yet what it intends to use it for. A PRV can be used to reduce an FDA ...
That means it needs to raise additional funding, and the biotech is looking at a number of options including the possible sale of priority review vouchers that it could receive from the FDA if ...
The Expert Panel for pay equity in the care and community sector has issued its initial decision in the Gender-based undervaluation - priority awards review (the Review). The Review considered whether ...
Similarly priced systems offer better performance and longer battery life, but HP's flagship convertible laptop boasts an ...
4h
Cornwall Live on MSNPerv who hid camera in woman's home among those sentenced by magistratesOn October 12, 2024, at Praze-an-Beeble in the County of Cornwall, drove a motor vehicle on the B3208 Cargenwyn when the ...
The federal agency tasked with protecting workers’ civil rights is classifying all new gender identity-related discrimination ...
A new southside fire station is among projects the Minot City Council will be looking at as the city finalizes a five-year, ...
Spokane Indivisible has announced a Rally for Science at 11 a.m. Saturday in Mission Park. What are they protesting about? “Science” is a very large subject; surely it can’t all be at risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results